JP2024527715A5 - - Google Patents

Info

Publication number
JP2024527715A5
JP2024527715A5 JP2023580416A JP2023580416A JP2024527715A5 JP 2024527715 A5 JP2024527715 A5 JP 2024527715A5 JP 2023580416 A JP2023580416 A JP 2023580416A JP 2023580416 A JP2023580416 A JP 2023580416A JP 2024527715 A5 JP2024527715 A5 JP 2024527715A5
Authority
JP
Japan
Prior art keywords
acceptable salt
pharmaceutical composition
ptexacyaninium
subject
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023580416A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024527715A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/056957 external-priority patent/WO2023007404A1/en
Publication of JP2024527715A publication Critical patent/JP2024527715A/ja
Publication of JP2024527715A5 publication Critical patent/JP2024527715A5/ja
Pending legal-status Critical Current

Links

JP2023580416A 2021-07-28 2022-07-27 イメージング用医薬組成物 Pending JP2024527715A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163226534P 2021-07-28 2021-07-28
US63/226,534 2021-07-28
PCT/IB2022/056957 WO2023007404A1 (en) 2021-07-28 2022-07-27 Pudexacianinium for nirf imaging

Publications (2)

Publication Number Publication Date
JP2024527715A JP2024527715A (ja) 2024-07-26
JP2024527715A5 true JP2024527715A5 (cg-RX-API-DMAC7.html) 2025-05-21

Family

ID=82898903

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023580416A Pending JP2024527715A (ja) 2021-07-28 2022-07-27 イメージング用医薬組成物

Country Status (9)

Country Link
US (1) US20240342316A1 (cg-RX-API-DMAC7.html)
EP (1) EP4376896A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024527715A (cg-RX-API-DMAC7.html)
KR (1) KR20240041952A (cg-RX-API-DMAC7.html)
CN (1) CN117715661A (cg-RX-API-DMAC7.html)
AU (1) AU2022321011A1 (cg-RX-API-DMAC7.html)
CA (1) CA3226034A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024001242A (cg-RX-API-DMAC7.html)
WO (1) WO2023007404A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024084287A1 (en) * 2022-10-21 2024-04-25 Astellas Pharma Inc. Composition for near infrared lymphatic imaging and uses and dosages therefor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9056131B2 (en) 2010-01-28 2015-06-16 National University Corporation Mie University Indocyanine compound, synthesis method and purification method thereof, diagnostic composition using the indocyanine compound, and device for measuring biokinetics and device for visualizing circulation using the diagnostic composition

Similar Documents

Publication Publication Date Title
RU2720204C1 (ru) Сублингвальная фармацевтическая композиция эдаравона и (+)-2-борнеола
HUE029677T2 (hu) Készítmények centrálisan mediált émelygés és hányás kezelésére
JP2024533423A5 (cg-RX-API-DMAC7.html)
JP2019533660A5 (cg-RX-API-DMAC7.html)
US20190175598A1 (en) Combination therapies for the treatment of hepatocellular carcinoma
JP2023115271A5 (cg-RX-API-DMAC7.html)
JP2025013684A (ja) 重度腎機能障害を有する癌患者に対する治療方法
JP2024539476A5 (cg-RX-API-DMAC7.html)
JPH0717867A (ja) 呼吸器官系疾患治療用薬剤
CN102300561B (zh) 包含依泽替米贝和辛伐他汀的药物组合物
JP2023510341A5 (ja) ナルブフィン治療可能障害を治療するために投与されるナルブフィン製剤
JP2024531799A5 (cg-RX-API-DMAC7.html)
JP2022177119A5 (cg-RX-API-DMAC7.html)
ES2286716T3 (es) Composicion farmaceutica de liberacion controlada y proceso para preparar la misma.
JP2024540439A5 (cg-RX-API-DMAC7.html)
JP6454436B1 (ja) ペマフィブラートを含有する医薬
US11833119B2 (en) Combination therapies for the treatment of hepatocellular carcinoma
EP1880722B1 (en) Pharmaceutical compositions of ciprofloxacin
US6653339B2 (en) Method of treating irritable bowel syndrome
RU2195937C1 (ru) Комбинированный противотуберкулезный препарат (ризобутол)
BR112020006658A2 (pt) métodos de tratamento de infecções bacterianas
JP2024506347A5 (cg-RX-API-DMAC7.html)
CN109715152A (zh) 医治感染的方法
JP2023502015A (ja) マルチターゲット型プロテインキナーゼ阻害剤の用途
CN117883432B (zh) 丹酚酸b的新用途